METTL1 and central nervous system cancer: Additionally, a comprehensive epitranscriptomic analysis of glioma further contextualizes m7G regulators, including METTL1/WDR4 and cap‐dependent readers, within key signalling networks, highlighting their clinical relevance in glioma progression.72